Preferential limbic expression of the cannabinoid receptor mRNA in the human fetal brain.
- Authors
- Wang, X; Dow-Edwards, D; Keller, E; Hurd, Y L
- Year
- 2003
- Journal
- Neuroscience
- PMID
- 12710976
- DOI
- 10.1016/s0306-4522(03)00020-4
The cannabinoid receptor one (CB1) is responsible for the effects of cannabis on motor and cognitive function in the CNS. There is to date very limited information about the CB1 gene expression in the human brain, in particular during fetal development. In the present study, in situ hybridization experiments were used to examine the microscopic and macroscopic organization of the CB1 mRNA expression in normal human fetal (approximately 20 weeks of development) and adult brains. The fetal brain showed a distinct heterogeneous pattern of the CB1 mRNA expression which was low to moderate in many brain areas. The most striking feature of the fetal brain was the intense expression in the hippocampal CA region and basal nuclear group of the amygdaloid complex. Many of the same brain areas that showed positive expression of the CB1 mRNA in the fetal brain also expressed the gene in the adult brain. However, aside from an intense expression in the hippocampus which resembled that in fetal brain, the adult brain showed very high expression throughout the cerebral cortex, caudate nucleus, putamen and cerebellar cortex. These results document a different pattern of the anatomical organization of the CB1 mRNA expression in the mid-gestation fetal and adult human brain. Overall, the high CB1 mRNA expression in the fetal hippocampus and amygdala indicates that these limbic structures might be most vulnerable to prenatal cannabis exposure.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| The genetic epidemiology of substance use disorder: A review. | 2017 | 28938182 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Age-Related Effects of Cannabis and Cannabinoids on Brain and Behavior. | Murray CH et al. | β | 2026 | β |
| Investigating Links Between Prenatal Cannabis Exposure and Brain Development Using Magnetic Resonance Imaging Techniques: A Narrative Review. | GonΓ§alves PD et al. | β | 2026 | β |
| Prenatal THC exposure and binge-like alcohol drinking in early adolescence: From sex-specific drinking vulnerability to abnormal endocannabinoid-dopamine nexus in the nucleus accumbens. | Castelli V et al. | β | 2026 | β |
| Cannabinoid Receptors in the Horse Lateral Nucleus of the Amygdala: A Potential Target for Ameliorating Pain Perception, Stress and Anxiety in Horses. | Bombardi C et al. | β | 2025 | β |
| High-intensity interval training exercise decreases brain CB1 receptor levels in male and female adult rats. | Tyler J et al. | β | 2025 | β |
| <i>In utero</i> chronic cannabis exposure is associated with lower total brain volume in the first month of postnatal life. | Crume TL et al. | β | 2025 | β |
| Modeling the Effect of Cannabinoid Exposure During Human Neurodevelopment Using Bidimensional and Tridimensional Cultures. | Estudillo E et al. | β | 2025 | β |
| Research Review: What we have learned about the endocannabinoid system in developmental psychopathology. | Tansey RC et al. | β | 2025 | β |
| Substance use and use disorders during pregnancy and the postpartum period. | Habersham LL et al. | β | 2025 | β |
| Synaptic signatures of perinatal cannabinoids: A systematic review of rodent hippocampal synaptic plasticity, learning, and memory. | Przy R et al. | β | 2025 | β |
| Transient CB2 receptor activation triggers irreversible luminal differentiation via chromatin remodeling in breast cancer | MartΓnez-Illescas NG et al. | β | 2025 | β |
| Aerobic Exercise and Endocannabinoids: A Narrative Review of Stress Regulation and Brain Reward Systems. | Gupta S et al. | β | 2024 | β |
| Birth, cognitive and behavioral effects of intrauterine cannabis exposure in infants and children: A systematic review and meta-analysis. | Sorkhou M et al. | β | 2024 | β |
| Cannabis, Endocannabinoids and Brain Development: From Embryogenesis to Adolescence. | Rodrigues RJ et al. | β | 2024 | β |
| Genetic and Neurodevelopmental Markers in Schizophrenia-Spectrum Disorders: Analysis of the Combined Role of the <i>CNR1</i> Gene and Dermatoglyphics. | Guardiola-Ripoll M et al. | β | 2024 | β |
| Maternal obesity induces sex-specific changes in the endocannabinoid system of the hypothalamus and dorsal hippocampus of offspring associated with anxiety-like behavior in adolescent female rats. | Calvino C et al. | β | 2024 | β |
| The impact of recreational cannabinoid legalization on utilization in a pregnant population. | Torres J et al. | β | 2024 | β |
| The relationship of prenatal acetaminophen exposure and attention-related behavior in early childhood. | Woodbury ML et al. | β | 2024 | β |
| CBD enhances the cognitive score of adolescent rats prenatally exposed to THC and fine-tunes relevant effectors of hippocampal plasticity. | Castelli V et al. | β | 2023 | β |
| Combined exposure to alcohol and cannabis during development: Mechanisms and outcomes. | KovΓ‘cs MV et al. | β | 2023 | β |
| Role of integrating cannabinoids and the endocannabinoid system in neonatal hypoxic-ischaemic encephalopathy. | Xiao J et al. | β | 2023 | β |
| The ethics and management of cannabis use in pregnancy following decriminalisation and licensing for medical use: narrative review. | Towobola A et al. | β | 2023 | β |
| Cell type specific cannabinoid CB1 receptor distribution across the human and non-human primate cortex. | Chou S et al. | β | 2022 | β |
| Lipid endocannabinoids in energy metabolism, stress and developmental programming. | Almeida MM et al. | β | 2022 | β |
| Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders. | Navarro D et al. | β | 2022 | β |
| Use of computational toxicology tools to predict <i>in vivo</i> endpoints associated with Mode of Action and the endocannabinoid system: A case study with chlorpyrifos, chlorpyrifos-oxon and <sup>Ξ9</sup>Tetrahydrocannabinol. | Silva M et al. | β | 2022 | β |
| Cannabis and synaptic reprogramming of the developing brain. | Bara A et al. | β | 2021 | β |
| Effect of prenatal marijuana exposure on sleep wake cycles and amplitude-integrated electroencephalogram (aEEG). | Pollack R et al. | β | 2021 | β |
| Effects of Cannabinoid Exposure during Neurodevelopment on Future Effects of Drugs of Abuse: A Preclinical Perspective. | Farrelly AM et al. | β | 2021 | β |
| How prenatal exposures shape the infant brain: Insights from infant neuroimaging studies. | Dufford AJ et al. | β | 2021 | β |
| Integrating Endocannabinoid Signalling In Depression. | Rana T et al. | β | 2021 | β |
| Maternal cannabis use is associated with suppression of immune gene networks in placenta and increased anxiety phenotypes in offspring. | Rompala G et al. | β | 2021 | β |
| Review of the Endocannabinoid System. | Lu HC et al. | β | 2021 | β |
| The Neurocognitive Effects of Cannabis Across the Lifespan. | Ellingson JM et al. | β | 2021 | β |
| Cannabis Exposure During Critical Windows of Development: Epigenetic and Molecular Pathways Implicated in Neuropsychiatric Disease. | Smith A et al. | β | 2020 | β |
| Cannabis use during pregnancy and its relationship with fetal developmental outcomes and psychiatric disorders. A systematic review. | Roncero C et al. | β | 2020 | β |
| Cannabis Use in Pregnant and Breastfeeding Women: Behavioral and Neurobiological Consequences. | Navarrete F et al. | β | 2020 | β |
| Interaction of maternal choline levels and prenatal Marijuana's effects on the offspring. | Hoffman MC et al. | β | 2020 | β |
| The novel MAGL inhibitor MJN110 enhances responding to reward-predictive incentive cues by activation of CB1 receptors. | Feja M et al. | β | 2020 | β |
| Consequences of Perinatal Cannabis Exposure. | Scheyer AF et al. | β | 2019 | β |
| Cortical GABAergic Dysfunction in Stress and Depression: New Insights for Therapeutic Interventions. | FogaΓ§a MV et al. | β | 2019 | β |
| Physiology of the Endocannabinoid System During Development. | Bukiya AN | β | 2019 | β |
| Contribution of Altered Endocannabinoid System to Overactive mTORC1 Signaling in Focal Cortical Dysplasia. | GarcΓa-RincΓ³n D et al. | β | 2018 | β |
| Exploiting the Multifaceted Effects of Cannabinoids on Mood to Boost Their Therapeutic Use Against Anxiety and Depression. | Stampanoni Bassi M et al. | β | 2018 | β |
| High times for cannabis: Epigenetic imprint and its legacy on brain and behavior. | Szutorisz H et al. | β | 2018 | β |
| Loren Parsons' contribution to addiction neurobiology. | De Luca MA et al. | β | 2018 | β |
| The Endocannabinoid System across Postnatal Development in Transmembrane Domain <i>Neuregulin 1</i> Mutant Mice. | Chesworth R et al. | β | 2018 | β |
| Cannabis-associated psychosis: Neural substrate and clinical impact. | Murray RM et al. | β | 2017 | β |
| Chronic exposure to cannabinoids during adolescence causes long-lasting behavioral deficits in adult mice. | Tomas-Roig J et al. | β | 2017 | β |
| Development and validation of a liquid chromatography tandem mass spectrometry method for the determination of cannabinoids and phase I and II metabolites in meconium. | Prego-Meleiro P et al. | β | 2017 | β |
| Role of the endocannabinoid system in vertebrates: Emphasis on the zebrafish model. | Oltrabella F et al. | β | 2017 | β |
| The genetic epidemiology of substance use disorder: A review. | Prom-Wormley EC et al. | β | 2017 | β |
| At the Tip of an Iceberg: Prenatal Marijuana and Its Possible Relation to Neuropsychiatric Outcome in the Offspring. | AlpΓ‘r A et al. | β | 2016 | β |
| Chromothripsis and epigenomics complete causality criteria for cannabis- and addiction-connected carcinogenicity, congenital toxicity and heritable genotoxicity. | Reece AS et al. | β | 2016 | β |
| Important role of endocannabinoid signaling in the development of functional vision and locomotion in zebrafish. | Martella A et al. | β | 2016 | β |
| Keep off the grass? Cannabis, cognition and addiction. | Curran HV et al. | β | 2016 | β |
| Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants. | Miliano C et al. | β | 2016 | β |
| Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis. | Bassir Nia A et al. | β | 2016 | β |
| Sex and age specific effects of delta-9-tetrahydrocannabinol during the periadolescent period in the rat: The unique susceptibility of the prepubescent animal. | Silva L et al. | β | 2016 | β |
| Sexually-dimorphic alterations in cannabinoid receptor density depend upon prenatal/early postnatal history. | Dow-Edwards D et al. | β | 2016 | β |
| Cortical thinness and volume differences associated with marijuana abuse in emerging adults. | Mashhoon Y et al. | β | 2015 | β |
| Developmental consequences of fetal exposure to drugs: what we know and what we still must learn. | Ross EJ et al. | β | 2015 | β |
| Endocannabinoid signalling in reward and addiction. | Parsons LH et al. | β | 2015 | β |
| Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes. | Higuera-Matas A et al. | β | 2015 | β |
| Sex-specific alterations in hippocampal cannabinoid 1 receptor expression following adolescent delta-9-tetrahydrocannabinol treatment in the rat. | Silva L et al. | β | 2015 | β |
| Developmental increase in hippocampal endocannabinoid mobilization: role of metabotropic glutamate receptor subtype 5 and phospholipase C. | Liang SL et al. | β | 2014 | β |
| Neuronal substrates and functional consequences of prenatal cannabis exposure. | Calvigioni D et al. | β | 2014 | β |
| Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies. | Maccarrone M et al. | β | 2014 | β |
| Trajectory of adolescent cannabis use on addiction vulnerability. | Hurd YL et al. | β | 2014 | β |
| Marijuana, Spice 'herbal high', and early neural development: implications for rescheduling and legalization. | Psychoyos D et al. | β | 2013 | β |
| Developmental regulation of CB1-mediated spike-time dependent depression at immature mossy fiber-CA3 synapses. | Caiati MD et al. | β | 2012 | β |
| Developmental trajectory of the endocannabinoid system in human dorsolateral prefrontal cortex. | Long LE et al. | β | 2012 | β |
| Endocannabinoids via CBβ receptors act as neurogenic niche cues during cortical development. | DΓaz-Alonso J et al. | β | 2012 | β |
| Gender-dependent behavioral and biochemical effects of adolescent delta-9-tetrahydrocannabinol in adult maternally deprived rats. | Zamberletti E et al. | β | 2012 | β |
| Type-1 cannabinoid receptor signaling in neuronal development. | Gaffuri AL et al. | β | 2012 | β |
| Lasting impacts of prenatal cannabis exposure and the role of endogenous cannabinoids in the developing brain. | Wu CS et al. | β | 2011 | β |
| Molecular mechanisms of maternal cannabis and cigarette use on human neurodevelopment. | Morris CV et al. | β | 2011 | β |
| Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models. | Malone DT et al. | β | 2010 | β |
| Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas. | De JesΓΊs ML et al. | β | 2010 | β |
| Requirement of cannabinoid CB(1) receptors in cortical pyramidal neurons for appropriate development of corticothalamic and thalamocortical projections. | Wu CS et al. | β | 2010 | β |
| Basic neuroanatomy and neuropharmacology of cannabinoids. | Breivogel CS et al. | β | 2009 | β |
| Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications. | Onaivi ES | β | 2009 | β |
| Developmental exposure to cannabinoids causes subtle and enduring neurofunctional alterations. | Campolongo P et al. | β | 2009 | β |
| Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome. | Jutras-Aswad D et al. | β | 2009 | β |
| The endocannabinoid system and the regulation of neural development: potential implications in psychiatric disorders. | Galve-Roperh I et al. | β | 2009 | β |
| The endocannabinoid system during development: emphasis on perinatal events and delayed effects. | Fride E et al. | β | 2009 | β |
| The polarised life of the endocannabinoid system in CNS development. | Anavi-Goffer S et al. | β | 2009 | β |
| Cannabis and the developing brain: insights from behavior. | Trezza V et al. | β | 2008 | β |
| Cannabis, cannabinoids and schizophrenia: integration of the evidence. | Cohen M et al. | β | 2008 | β |
| Endocannabinoid functions controlling neuronal specification during brain development. | Harkany T et al. | β | 2008 | β |
| Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning. | Mulder J et al. | β | 2008 | β |
| Leptin receptor deficiency is associated with upregulation of cannabinoid 1 receptors in limbic brain regions. | Thanos PK et al. | β | 2008 | β |
| Multiple roles for the endocannabinoid system during the earliest stages of life: pre- and postnatal development. | Fride E | β | 2008 | β |
| Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia. | Eggan SM et al. | β | 2008 | β |
| Hardwiring the brain: endocannabinoids shape neuronal connectivity. | Berghuis P et al. | β | 2007 | β |
| The emerging functions of endocannabinoid signaling during CNS development. | Harkany T et al. | β | 2007 | β |
| Cannabis and neurodevelopment: implications for psychiatric disorders. | Sundram S | β | 2006 | β |
| Characterization of CB1 cannabinoid receptor immunoreactivity in postmortem human brain homogenates. | De JesΓΊs ML et al. | β | 2006 | β |
| Discrete opioid gene expression impairment in the human fetal brain associated with maternal marijuana use. | Wang X et al. | β | 2006 | β |
| Neuroimaging of prenatal drug exposure. | Dow-Edwards DL et al. | β | 2006 | β |
| [Short- and long-term consequences of prenatal exposure to cannabis]. | Karila L et al. | β | 2006 | β |
| Developmental expression of cannabinoid receptors in the chick retinotectal system. | Leonelli M et al. | β | 2005 | β |
| Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor. | Berghuis P et al. | β | 2005 | β |
| Evaluation of the effect of age on cannabinoid receptor functionality and expression in guinea-pig ileum longitudinal muscle-myenteric plexus preparations. | Abalo R et al. | β | 2005 | β |
| Prodynorphin transcripts and proteins differentially expressed and regulated in the adult human brain. | Nikoshkov A et al. | β | 2005 | β |
| The safety of cannabinoids for the treatment of multiple sclerosis. | Smith PF | β | 2005 | β |
| Cannabinoids and gene expression during brain development. | FernΓ‘ndez-Ruiz J et al. | β | 2004 | β |
| In utero marijuana exposure associated with abnormal amygdala dopamine D2 gene expression in the human fetus. | Wang X et al. | β | 2004 | β |
| The endocannabinoid-CB(1) receptor system in pre- and postnatal life. | Fride E | β | 2004 | β |